Apl. Prof. Dr. med. Klaus Golka

golka

Clinical occupational medicine

Phone: +49 / 231 1084 344
Email: golka@ifado.de

Curriculum Vitae:

  • 07/06 apl.-Prof. at the Ruhr-University Bochum
  • 10/99 Thesis for habilitation at the Ruhr-University Bochum for "Occupational Medicine"
  • 2/95 Certified for environmental medicine
  • 9/89 Specialist in occupational medicine
  • 8/87 Postdoctoral research fellow at the IfADo Research Centre for Working Environment and Human Factors
  • 1/86 Degree to Dr. med., Justus-Liebig-University Gießen
  • 9/84-7/87 Residency, Hospital for Psychosomatic and Internal Medicine "Am Hasenbach", Clausthal-Zellerfeld
  • 2/83-5/84 Residency in internal medicine, Hospital of the County of Gießen, Academic Teaching Hospital, Justus-Liebig-University Gießen
  • 11/82 Medical doctor
  • 10/76-10/82 Study of human medicine at the Justus-Liebig-University Gießen, Germany

Research topics:

  • Occupational and non-occupational causes of cancer of the urogenital tract and the impact of xenobiotic metabolising enzymes and ethnicity

Key publications:

  • Golka, K.; Schöps, W.; Prager, H. M.; Hallier, E.: Polyzyklische aromatische Kohlenwasserstoffe (BK 1321)
    In: Krebs und Arbeit: Arbeits- und sozialmedizinische Aspekte (S. S. 252-262) / Letzel - Schmitz-Spanke - Lang - Nowak (Hrsg.). Landsberg: ecomed-Storck GmbH, 2021.
    I am interested in this work
  • Golka, K.; Schöps, W.: Aromatische Amine (BK 1301)
    In: Krebs und Arbeit: Arbeits- und sozialmedizinische Aspekte (S. S. 184-202) / Letzel - Schmitz-Spanke - Lang - Nowak (Hrsg.). Landsberg: ecomed-Storck GmbH, 2021.
    I am interested in this work
  • Kadhum, T.; Kopps, S.; Bolt, H. M.; Blaszkewicz, M.; Reinders, J.; Hengstler, J. G.; Selinski, S.; Golka, K.: Harnblasenkrebs durch Rissprüfsprays auf Azofarbstoff-Basis
    Zbl. Arbeitsmed. 71: 1-7 (2021)
    https://doi.org/10.1007/s40664-020-00406-6
    I am interested in this work
  • Leitlinienprogramm Onkologie: S3 –Leitlinie Diagnostik, Therapie und Nachsorge des Nierenzellkarzinoms ; Langversion 2.0 – August 2020, AWMF-Registernummer: 043/017OL . Berlin: Office Leitlinienprogramm Onkologie, 2020.
    I am interested in this work
    https://www.leitlinienprogramm-onkologie.de/leitlinien/nierenzellkarzinom/
  • Schöps, W.; Böthig, R.; Buntrock, S.; Forchert, M.; Jungmann, O. P.; Kaufmann, A.; Zellner, M.; Golka, K.: Urologische Begutachtung
    In: Kursbuch der ärztlichen Begutachtung (S. 60. Erg.-Lfg., Dez. 2020 (S. VI-8.1-VI-8.11)) / E. Ludolph ; J. Schürmann ; P. W. Gaidzik. Landsberg: ecomed, 2020.
    I am interested in this work
  • Böthig, R.; Golka, K.; Tiburtius, C.; Balzer, O.; Kowald, B.; Schöps, W.; Kadhum, T.; Thietje, R.: Incidental bladder cancer at initial urological workup of spinal cord injury patients
    Spinal Cord Series and Cases 6: 55 (6 pp) (2020)
    I am interested in this work
    https://doi.org/10.1038/s41394-020-0307-4
  • Yu, E. Y. W.; Wesselius, A.; Sinhart, C.; Wolk, A.; Stern, M. C.; Jiang, X.; Golka, K.; Zeegers, M. P. A.: ¬A¬ data mining approach to investigate food groups related to incidence of bladder cancer in the BLadder cancer Epidemiology and Nutritional Determinants International Study
    Br. J. Nutr. 124: 611-619 (2020)
    https://dx.doi.org/10.1017/S0007114520001439
    I am interested in this work
  • Kleinbeck, S.; Schäper, M.; Pacharra, M.; Lehmann, M. L.; Golka, K.; Blaszkewicz, M.; Brüning, T.; van Thriel, C.: ¬A¬ short-term inhalation study to assess the reversibility of sensory irritation in human volunteers
    Arch. Toxicol. 94: 1687-1701 (2020)
    https://doi.org/10.1007/s00204-020-02703-8
    I am interested in this work
  • Bönnemann, V.; Claus, M.; Butzeck, B.; Collette, D.; Bröde, P.; Golka, K.; Watzl, C.: Analysis of Natural Killer cell functions in patients with hereditary hemochromatosis
    EXCLI J. 19: 430-441 (2020)
    I am interested in this work
    https://dx.doi.org/10.17179/excli2020-1116
  • Huang-Tiel, H. J.; Otto, I.; Golka, K.; Selinski, S.; Koswig, S.; Bathe, K.; Hallmann, S.; Ecke, T. H.: Health-related quality of life and rates of toxicity after high-dose-rate brachytherapy in combination with external beam radiation therapy for high-risk prostate cancer
    Investig. Clin. Urol. 61: 250-259 (2020)
    I am interested in this work
    https://dx.doi.org/10.4111/icu.2020.61.3.250